Related by context. Frequent words. (Click for all words.) 67 axitinib 65 randomized Phase III 65 phase IIa 64 phase IIb 64 Phase 2a clinical 63 Phase 1b clinical 63 ECOG 62 nab paclitaxel 62 EORTC 62 Phase 1a 62 Phase IIa clinical 62 phase 2a 62 metastatic renal cell carcinoma 62 Pharmacokinetic 62 temsirolimus 61 Phase Ia 61 plus prednisone 61 Phase 2a trial 61 Phase IIb clinical 61 Phase Ib 61 placebo controlled randomized 60 aflibercept 60 randomized Phase 60 Phase 2b clinical 60 ZYBRESTAT 60 Phase 2b study 60 neoadjuvant 60 Phase III randomized 60 Clinical Trial Results 60 Phase III pivotal 59 PXD# 59 IMGN# 59 tocilizumab 59 dose escalation trial 59 TORISEL 59 TELCYTA 59 subgroup analyzes 59 CA4P 59 Phase 1b trial 59 Phase 1b 59 Phenoptin 59 Phase III Trial 59 TG# [001] 59 hepatocellular carcinoma HCC 59 evaluable patients 59 HGS ETR1 59 unresectable 59 Phase IIa trial 59 Phase 2b trial 58 talactoferrin 58 FOLFOX 58 antitumor activity 58 confirmatory Phase III 58 evaluable 58 decitabine 58 azacitidine 58 AP# [003] 58 thymalfasin 58 teduglutide 58 CoFactor 58 vandetanib 58 Phase 2b 58 Chronic Lymphocytic Leukemia 58 Azixa 58 noninferiority 58 L MTP PE 58 RTOG 57 relapsed multiple myeloma 57 interferon alfa 57 HRPC 57 multicenter randomized 57 Taxotere ® 57 ADXS# 57 dose cohorts 57 sunitinib 57 Chronic Hepatitis C 57 maribavir 57 TroVax 57 HuMax CD# 57 mCRC 57 neoadjuvant chemotherapy 57 FOLFIRI 57 median PFS 57 Monotherapy 57 CYT# 57 orally bioavailable 57 RG# [001] 57 dacarbazine 57 Secondary endpoints 57 Initiates Phase 57 bosentan 57 seliciclib 57 pivotal Phase 57 Torisel 57 GVAX 57 PF # [001] 56 relapsed refractory 56 OXi# 56 prospective randomized controlled 56 Bortezomib 56 ASA#